Management of the Acute Exacerbation of Asthma

Journal of Asthma

Volumn 40, Issue 6, 2003, Pages 593-604

  Roy, Sitesh R ^a,b   Milgrom, Henry ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOPHYLLINE; ANTIHISTAMINIC AGENT; ATROPINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FORMOTEROL; HELIOX; IPRATROPIUM BROMIDE; LEVALBUTEROL; MAGNESIUM SULFATE; METHYLPREDNISOLONE; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYGEN; SALBUTAMOL; SALMETEROL; TERBUTALINE;

AIRWAY OBSTRUCTION; ANXIETY DISORDER; ASTHMA; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; HEART DISEASE; HEART MUSCLE ISCHEMIA; HUMAN; HYPOREFLEXIA; HYPOTENSION; METERED DOSE INHALER; PRACTICE GUIDELINE; REVIEW; TACHYCARDIA; TREMOR; VOMITING;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; ANOXIA; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHILD, PRESCHOOL; CHOLINERGIC ANTAGONISTS; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; EMERGENCY TREATMENT; HELIUM; HUMANS; INFANT; INJECTIONS, INTRAVENOUS; OXYGEN; OXYGEN INHALATION THERAPY; PRACTICE GUIDELINES; SELF CARE;

EID: 0142117168     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120018776     Document Type: Review

References (59)

1. Mannino D, Homa D, Akinbami L, Moorman J, Gwynn C, Redd S. Surveillance for asthma-United States, 1980-1999. MMWR 2002; 51:1-14.
2. National Institutes of Health, National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma 1997; Publ. No. 97-4051.
3. British Thoracic Society. The British Guidelines on Asthma management: 1995 Review and Position Statement. Thorax 1997; 52:S1-21.
4. GINA. 1995. Practical Guide for Asthma Management. http://www.ginasthma.com:80/ xprac.html 1995.
5. Holgate ST, Frew AJ. Choosing therapy for childhood asthma. N Engl J Med 1997; 337(23):1690-1692.
6. Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG, Hogg JC. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997; 100(1):44-51.
7. Redington AE, Howarth PH. Airway wall remodelling in asthma. Thorax 1997; 52(4), 310-312.
8. Helms PJ. Early environmental influences in the development of asthma and atopic disease. Monaldi Arch Chest Dis 2001; 56(3):265-269.
9. Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002; 324(7340):763-767.
10. McFadden ER Jr, Hejal RB. The pathobiology of acute asthma. Clin Chest Med 2000; 21(2):213-224.
11. Martinez FD. Recognizing early asthma. Allergy 1999; 54(suppl 49):24-28.
12. Stein RT, Holberg CJ, Morgan WJ, Wright AL, Lombardi E, Taussig L, Martinez FD. Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood. Thorax 1997; 52(11):946-952.
13. Milgrom H, Wood RI, Ingram D. Respiratory conditions that mimic asthma. Immunol Allergy Clin N Am 1998; 18:113-132.
14. Idris AH, McDermott MF, Raucci JC, Morrabel A, McGorray S, Hendeles L. Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest 1993; 103(3):665-672.
15. Closa RM, Ceballos JM, Gomez-Papi A, Galiana AS, Gutierrez C, Marti-Henneber C. Efficacy of bronchodilators administered by nebulizers vs. spacer devices in infants with acute wheezing. Pediatr Pulmonol 1998; 26(5):344-348.
16. Cates C, Rowe B, Bara A. Holding chambers vs. nebulizers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2002; 2:CD000052.
17. Beasley R, Pearce N, Crane J, Burgess C. Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol 1999; 104(2 Pt 2):S18-30.
18. Anis AH, Lynd LD, Wang XH, King G, Spinelli JJ, Fitzgerald M, Bai T, Pare P. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 2001; 164(5):625-631.
19. Templeton AG, Chapman ID, Chilvers ER, Morley J, Handley DA. Effects of S-salbutamol on human isolated bronchus. Pulm Pharmacol Ther 1998; 11(1):1-6.
20. Baramki D, Koester J, Anderson AJ, Borish L. Modulation of T-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer. J Allergy Clin Immunol 2002; 109(3):449-454.
21. Cockcroft DW, Davis BE, Swystun VA, Marciniuk DD. Tolerance to the bronchoprotective effect of beta2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo. J Allergy Clin Immunol 1999; 103(6):1049-1053.
22. Lotvall J, Palmqvist M, Arvidsson P, Maloney A, Ventresca GP, Ward J. The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients. J Allergy Clin Immunol 2001; 108(5):726-731.
23. Ahrens R, Weinberger M. Levalbuterol and racemic albuterol: are there therapeutic differences? J Allergy Clin Immunol 2001; 108(5):681-684.
24. Milgrom H, Skoner DP, Bensch G, Kim KT, Claus R, Baumgartner RA. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol. J Allergy Clin Immunol 2001; 108(6):938-945.
25. Nelson HS, Bensch G, Pleskow WW, DiSantostefano R, DeGraw S, Reasner DS, Rollins TE, Rubin PD. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol 1998; 102(6 Pt 1):943-952.
26. Selroos O. Formoterol used as needed-clinical effectiveness. Respir Med 2001; 95(suppl B): S17-S20.
27. Tattersfield AE, Lofdahl CG, Postma DS, Eivindson A, Schreurs AG, Rasidakis A, Ekstrom T. Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomized trial. Lancet 2001; 357(9252): 257-261.
28. 2 as a predictor of outcome in 280 children presenting with acute asthma. Ann Emerg Med 1994; 23(6): 1236-1241.
29. Chien JW, Ciufo R, Novak R, Skowronski M, Nelson J, Coreno A, McFadden ER Jr. Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest 2000; 117(3):728-733.
30. O'Driscoll BR, Kalra S, Wilson M, Pickering CA, Carroll KB, Woodcock AA. Double-blind trial of steroid tapering in acute asthma. Lancet 1993; 341(8841):324-327.
31. Rodrigo G, Rodrigo C. Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med 1998; 157(3 Pt 1):698-703.
32. Volovitz B, Bentur L, Finkelstein Y, Mansour Y, Shalitin S, Nussinovitch M, Varsano I. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol 1998; 102(4 Pt 1):605-609.
33. Schuh S, Reisman J, Alshehri M, Dupuis A, Corey M, Arseneault R, Alothman G, Tennis O, Canny G. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med 2000; 343(10):689-694.
34. Edmonds M, Camargo C, Pollack C, Rowe B. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 2001; 1:CD002308.
35. Rowe BH, Bota GW, Fabris L, Therrien SA, Milner RA, Jacono J. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial. JAMA 1999; 281(22):2119-2126.
36. Ratto D, Alfaro C, Sipsey J, Glovsky MM, Sharma OP. Are intravenous corticosteroids required in status asthmaticus? JAMA 1988; 260(4):527-529.
37. Parameswaran K, Belda J, Rowe B. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Syst Rev 2000; 4:CD002742.
38. Travers A, Jones A, Kelly K, Barker S, Camargo C, Rowe B. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev 2001; 2:CD002988.
39. Qureshi F, Pestian J, Davis P, Zaritsky A. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med 1998; 339(15):1030-1035.
40. Rodrigo GJ, Rodrigo, C. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med 2000; 161(6):1862-1868.
41. Stoodley RG, Aaron SD, Dales RE. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials. Ann Emerg Med 1999; 34(1):8-18.
42. Rowe B, Bretzlaff J, Bourdon C, Bota G, Camargo C. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000; 2:CD001490.
43. Rodrigo G, Rodrigo C, Pollack C, Travers A. Helium-oxygen mixture for non-intubated acute asthma patients. Cochrane Database Syst Rev 2001; 2.
44. Kress JP, Noth I, Gehlbach BK, Barman N, Pohlman AS, Miller A, Morgan S, Hall JB. The utility of albuterol nebulized with heliox during acute asthma exacerbations. Am J Respir Crit Care Med 2002; 165(9):1317-1321.
45. de Blic J, Delacourt C, Le Bourgeois M, Mahut B, Ostinelli J, Caswell C, Scheinmann P. Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study. J Allergy Clin Immunol 1996; 98(1):14-20.
46. Ilangovan P, Pedersen S, Godfrey S, Nikander K, Noviski N, Warner JO. Treatment of severe steroid dependent preschool asthma with nebulized budesonide suspension. Arch Dis Child 1993; 68(3):356-359.
47. Garrett J, Williams S, Wong C, Holdaway D. Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid. Arch Dis Child 1998; 79(1):12-17.
48. McFadden ER Jr, Elsanadi N, Dixon L, Takacs M, Deal EC, Boyd KK, Idemoto BK, Broseman LA, Panuska J, Hammons T, Smith B, Caruso F, McFadden CB, Shoemaker L, Warren EL, Hejal RB, Strauss L, Gilbert IA. Protocol therapy for acute asthma: therapeutic benefits and cost savings. Am J Med 1995; 99(6):651-661.
49. Shrestha M, Bidadi K, Gourlay S, Hayes J. Continuous vs. intermittent albuterol, at high and low doses, in the treatment of severe acute asthma in adults. Chest 1996; 110(1):42-47.
50. Schuh S, Parkin P, Rajan A, Canny G, Healy R, Rieder M, Tan YK, Levison H, Soldin SJ. High-vs. low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics 1989; 83(4):513-518.
51. Emerman CL, Cydulka RK. Factors associated with relapse after emergency department treatment for acute asthma. Ann Emerg Med 1995; 26(1)::6-11.
52. Emerman CL, Woodruff PG, Cydulka RK, Gibbs MA, Pollack CV Jr, Camargo CA Jr. Prospective multicenter study of relapse following treatment for acute asthma among adults presenting to the emergency department. MARC investigators. Multicenter Asthma Research Collaboration. Chest 1999; 115(4):919-927.
53. Marquette CH, Saulnier F, Leroy O, Wallaert B, Chopin C, Demarcq JM, Durocher A, Tonnel AB. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 1992; 146(1):76-81.
54. Newman KB, Mason UG 3rd, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med 1995; 152(4 Pt 1): 1382-1386.
55. Wood RP 2nd, Milgrom H. Vocal cord dysfunction. J Allergy Clin Immunol 1996; 98(3):481-485.
56. Mak H, Johnston P, Abbey H, Talamo R. Prevalence of asthma and health service utilization of asthmatic children in an inner city. J Allergy Clin Immunol 1982; 70(5): 367-372.
57. Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 1996; 98(2 Pt 1):196-200.
58. Lieu TA, Quesenberry CP Jr, Capra AM, Sorel ME, Martin KE, Mendoza GR. Outpatient management practices associated with reduced risk of pediatric asthma hospitalization and emergency department visits. Pediatrics 1997; 100(3 Pt 1):334-341.
59. Petty, T. Personal communication.